Pseudomonas aeruginosa Bloodstream Infection: Importance of Appropriate Initial Antimicrobial Treatment

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2005-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1128/AAC.49.4.1306-1311.2005PMID 15793102PMCID PMC1068618
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Performance standards for antimicrobial disk susceptibility tests : approved standard

  2006cited by this paper
• β lactam monotherapy versus β lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials

  2004cited by this paper
• Hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa.

  2004cited by this paper
• Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.

  2003cited by this paper
• β lactam monotherapy versus β lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis

  2003cited by this paper
• Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia.

  2003cited by this paper
• Applying the 3M All Patient Refined Diagnosis Related Groups Grouper to Measure Inpatient Severity in the VA

  2003cited by this paper
• The clinical evaluation committee in a large multicenter phase 3 trial of drotrecogin alfa (activated) in patients with severe sepsis (PROWESS): Role, methodology, and results*

  2003cited by this paper
• Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis.

  2003cited by this paper
• Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia.

  2003cited by this paper
• Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities

  2003cited by this paper
• Effectiveness of Combination Antimicrobial Therapy for Pseudomonas aeruginosa Bacteremia

  2003cited by this paper
• Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis*

  2003cited by this paper
• Jumping Versus Nonjumping Anterior Cruciate Ligament Injuries: A Comparison of Pathology

  2003cited by this paper
• Epidemiology and prognostic determinants of bloodstream infections in surgical intensive care.

  2002cited by this paper
• Antibiotic Resistance in the Intensive Care Unit

  2001cited by this paper
• Experience with a clinical guideline for the treatment of ventilator-associated pneumonia

  2001cited by this paper
• Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates.

  2001cited by this paper
• Pseudomonas aeruginosa bacteremia in children: analysis of trends in prevalence, antibiotic resistance and prognostic factors

  2000cited by this paper
• Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: Retrospective analysis of 245 episodes.

  2000influential reference
• Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients.

  2000cited by this paper
• The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting.

  2000influential reference
• Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.

  1999cited by this paper
• Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System.

  1999cited by this paper
• The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia.

  1998cited by this paper
• Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

  1998cited by this paper
• The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults.

  1997cited by this paper
• The value of routine microbial investigation in ventilator-associated pneumonia.

  1997cited by this paper
• A Randomized, Prospective Evaluation of an Interventional Program to Discontinue Intravenous Antibiotics at Two Tertiary Care Teaching Institutions

  1997cited by this paper
• Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes.

  1996cited by this paper
• The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee.

  1995cited by this paper
• Controlled evaluation of 5 versus 10 milliliters of blood cultured in aerobic BacT/Alert blood culture bottles

  1994cited by this paper
• The Risk of Determining Risk with Multivariable Models

  1993cited by this paper
• Antibiotic therapy for the febrile granulocytopenic cancer patient: combination therapy vs. monotherapy.

  1989cited by this paper
• Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.

  1986cited by this paper
• Pseudomonas bacteremia. Retrospective analysis of 410 episodes.

  1985cited by this paper
• A simplified acute physiology score for ICU patients

  1984cited by this paper
• Analysis of 1,186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy.

  1983cited by this paper
• National Committee for Clinical Laboratory Standards.

  1980cited by this paper

• Studiu asupra spectrului etiologic și rezistenței la antibiotice a germenilor implicați în infecții sistemice într-un spital multidisciplinar | [Study on the etiological spectrum and antibiotic resistance of germs involved in bloodstream infections in a ...]

  2026cites this paper
• Genomic variants distinguish Pseudomonas aeruginosa from cystic fibrosis sputum and bloodstream infection

  2026cites this paper
• [From laboratory to bedside: Interpreting the antibiogram in clinical care].

  2026cites this paper
• Incidence and resistance rates of Pseudomonas aeruginosa bloodstream infections in Switzerland: a nationwide surveillance study (2010–2022)

  2025cites this paper
• Risk factors for 30-Day mortality and the role of empirical therapy in Pseudomonas aeruginosa bloodstream infections

  2025cites this paper
• Evaluation of Adjunctive Aminoglycoside Therapy Compared to β-Lactam Monotherapy in Critically Ill Patients with Gram-Negative Bloodstream Infections

  2025cites this paper
• Virulence factors, molecular characteristics, and resistance mechanisms of carbapenem-resistant Pseudomonas aeruginosa isolated from pediatric patients in Shanghai, China

  2025cites this paper
• Pseudomonas aeruginosa: ecology, evolution, pathogenesis and antimicrobial susceptibility

  2025cites this paper
• Improved Pseudomonas aeruginosa detection through the development of an engineered reporter bacteriophage.

  2025cites this paper
• A decade of antimicrobial resistance trends in Pseudomonas aeruginosa: insights from a tertiary care hospital in Saudi Arabia (2013–2022)

  2025cites this paper
• Immunomodulation by extracorporeal ozone-based bactericide system in porcine Pseudomonas aeruginosa septic shock

  2025cites this paper
• Contemporary Guidelines for the Treatment and Prevention of Nosocomial Infections: Critical Analysis and Practical Perspectives.

  2025cites this paper
• Effect of empiric antibiotics against Pseudomonas aeruginosa on mortality in hospitalized patients: a systematic review and meta-analysis.

  2024cites this paper
• The Presence of Four Pathogenic Oral Bacterial Species in Six Wild Snake Species from Southern Taiwan: Associated Factors

  2024cites this paper
• Short Versus Prolonged Duration of Therapy for Pseudomonas aeruginosa Bacteremia: A Systematic Review and Meta-analysis.

  2024cites this paper
• A randomized non-inferiority study comparing imipenem/cilastatin/relebactam with standard-of-care Gram-negative coverage in cancer patients with febrile neutropenia.

  2024cites this paper
• Effects of meropenem supply restriction: A multicenter retrospective study.

  2024cites this paper
• Relationship between Target Time above Minimum Inhibitory Concentration Achievement Rate of Meropenem Using Monte Carlo Simulation and In-Hospital Survival in Patients with Pseudomonas aeruginosa Bacteremia

  2024cites this paper
• 14-Year Epidemiologic study of Pseudomonas aeruginosa bloodstream infection incidence and resistance in the Veterans Health Administration system, 2009–2022

  2024cites this paper
• Risk factors and outcomes of inpatients with carbapenem-resistant Pseudomonas aeruginosa bloodstream infections in China: a 9-year trend and multicenter cohort study

  2023cites this paper
• Age of Antibiotic Resistance in MDR/XDR Clinical Pathogen of Pseudomonas aeruginosa

  2023cites this paper
• Identification and antibiotics Sensitivity of Secondary Bacterial Infection in COVID-19 (SARS-CoV-2) Pneumonia patients in Kirkuk/Iraq

  2023cites this paper
• Pseudomonas—Spectrum of Disease Presentations for the Inpatient Dermatologist

  2023cites this paper
• Fulminant ruptured septic aneurysm complicating the catheter related blood stream infection in a patient on maintenance hemodialysis: A case report

  2023cites this paper
• Applicability and limitations of quality indicator-based assessment of appropriateness in antimicrobial use: a comparison with expert opinion.

  2023cites this paper
• In vitro activity of ceftolozane/tazobactam against multidrug-resistant Pseudomonas aeruginosa from patients in Western Europe: SMART 2017-2020.

  2023cites this paper
• Delayed host mortality and immune response upon infection with P. aeruginosa persister cells

  2023cites this paper
• Development of a Polymicrobial Checkerboard Assay as a Tool for Determining Combinatorial Antibiotic Effectiveness in Polymicrobial Communities

  2023cites this paper
• BIChromET: A Chromogenic Culture Medium for Detection of Piperacillin/Tazobactam and Cefepime Resistance in Pseudomonas aeruginosa

  2023cites this paper
• A 10-year microbiological study of Pseudomonas aeruginosa strains revealed the circulation of populations resistant to both carbapenems and quaternary ammonium compounds

  2023cites this paper
• Evaluation of the Reveal® rapid AST system to assess the susceptibility of Pseudomonas aeruginosa from blood cultures

  2023cites this paper
• Pseudomonas Bacteremia in Children: Clinical and Microbiologic Features and Risk Factors of Mortality: A Retrospective Cohort Study

  2023cites this paper
• Early deaths associated with community-acquired and healthcare-associated bloodstream infections: a population-based study, Finland, 2004 to 2018

  2022cites this paper
• Outcomes of octogenarians and nonagenarians with Pseudomonas aeruginosa bacteremia: a multicenter retrospective study

  2022cites this paper
• Detection of extended spectrum β-Lactamase (ESBL) and Metallo β-Lactamase (MBL) in Pseudomonas aeruginosa isolated from various clinical samples

  2022cites this paper
• A ten-year microbiological study of Pseudomonas aeruginosa strains revealed diffusion of carbapenems and quaternary ammonium compounds resistant populations

  2022cites this paper
• Risk factors for colonization and infection with multidrug-resistant Pseudomonas aeruginosa in intensive care unit: protocol for a systematic review and meta-analysis

  2022cites this paper
• Neonatal Septicemia: Clinical and Epidemiological Features

  2022cites this paper
• Comparative Analysis of Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa and Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae

  2022cites this paper
• Evaluation of Wound Healing and Antibacterial Potential of Greyia radlkoferi Szyszyl. Ethanolic Leaf Extract

  2022cites this paper
• Effects of Inappropriate Administration of Empirical Antibiotics on Mortality in Adults With Bacteraemia: Systematic Review and Meta-Analysis

  2022cites this paper
• A review of recent advances in the treatment of adults with complicated urinary tract infection

  2022cites this paper
• Development of a combination antibiogram for empirical treatments of Pseudomonas aeruginosa at a university-affiliated teaching hospital.

  2022cites this paper
• Antimicrobial Treatment of Pseudomonas aeruginosa Severe Sepsis

  2022cites this paper
• The activity of Aloe arborescens Miller varieties on wound-associated pathogens, wound healing and growth factor production

  2022cites this paper
• A Prospective Randomized Study Comparing Ceftolozane/Tazobactam to Standard of Care in the Management of Neutropenia and Fever in Patients With Hematological Malignancies

  2022cites this paper
• Antimicrobial resistance in Gram-negative bacilli in Spain: an experts’ view

  2022cites this paper
• Pseudomonas aeruginosa Pneumonia: Evolution of Antimicrobial Resistance and Implications for Therapy.

  2022cites this paper
• PaP1, a Broad-Spectrum Lysin-Derived Cationic Peptide to Treat Polymicrobial Skin Infections

  2022cites this paper
• STRATEGIES TO APPLICATION OF PHENOTYPIC AND GENOTYPIC IDENTIFY PSEUDOMONAS AERUGINOSA

  2022cites this paper
• Infectious Disease Consults of Pseudomonas aeruginosa Bloodstream Infection and Impact on Health Outcomes.

  2022cites this paper
• Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa: In Vivo and In Vitro Evidence

  2022cites this paper
• Vaccination to Prevent Pseudomonas aeruginosa Bloodstream Infections

  2022cites this paper
• Demonstration of the efficacy of curcumin on carbapenem-resistant Pseudomonas aeruginosa with Galleria mellonella larvae model

  2022cites this paper
• Short versus prolonged courses of antimicrobial therapy for patients with uncomplicated Pseudomonas aeruginosa bloodstream infection: a retrospective study.

  2021cites this paper
• Clinical characteristics, appropriateness of empiric antibiotic therapy, and outcome of Pseudomonas aeruginosa bacteremia across multiple community hospitals

  2021cites this paper
• Combination antibiotic therapy versus monotherapy in the treatment of acute exacerbations of chronic obstructive pulmonary disease: an open-label randomized trial

  2021cites this paper
• Pseudomonas aeruginosa Positivity and Sensitivity in Invasive Bloodstream Infections Using Automated Bactec in Tertiary Care Teaching Hospital of North India

  2021cites this paper
• The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update

  2021cites this paper
• Predictors of multidrug resistant Pseudomonas aeruginosa involvement in bloodstream infections

  2021cites this paper
• Creation of a Combination Antibiogram for Pseudomonas aeruginosa in a Pediatric Intensive Care Unit.

  2021cites this paper
• Risk Factors for Colonization and Infection With Resistant Pseudomonas Aeruginosa in Intensive Care Unit: Protocol for a Systematic Review and Meta-analysis

  2021cites this paper
• Ceftolozane/Tazobactam and Imipenem/Relebactam Cross-Susceptibility Among Clinical Isolates of Pseudomonas aeruginosa From Patients With Respiratory Tract Infections in ICU and Non-ICU Wards—SMART United States 2017–2019

  2021cites this paper
• A Europium-Organic Framework Sensing Material for 2-Aminoacetophenone, a Bacterial Biomarker in Water.

  2021cites this paper
• High pyocyanin production and non-motility of Pseudomonas aeruginosa isolates are correlated with septic shock or death in bacteremic patients

  2021cites this paper
• Successfully controlling the incidence of multidrug‐resistant Pseudomonas aeruginosa through antibiotic stewardship and infection control programmes at a Chinese university hospital

  2021cites this paper
• Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients

  2021cites this paper
• Phenotypic and Genotypic Analysis of the Antibiotic Resistance Profiles of Gram Negative Bacteria Isolated from the Blood Culture Samples

  2021cites this paper
• Rapid and Accurate Detection of Aminoglycoside-Modifying Enzymes and 16S rRNA Methyltransferases by Targeted Liquid Chromatography-Tandem Mass Spectrometry

  2021influential citation
• An Organ System-Based Synopsis of Pseudomonas aeruginosa Virulence

  2021cites this paper
• Developing Machine-Learning Prediction Algorithm for Bacteremia in Admitted Patients

  2021cites this paper
• Pathogenesis of Gram-Negative Bacteremia

  2021cites this paper
• N-3-oxododecanoyl homoserine lactone exacerbates endothelial cell death by inducing receptor-interacting protein kinase 1-dependent apoptosis.

  2021cites this paper
• Beta-lactam monotherapy or combination therapy for bloodstream infections or pneumonia due to P. aeruginosa: a meta-analysis.

  2021cites this paper
• Rapid fluoroquinolone resistance detection in Pseudomonas aeruginosa using mismatch amplification mutation assay-based real-time PCR

  2021cites this paper
• Electrochemical sensors for detection of Pseudomonas aeruginosa virulence biomarkers: principles of design and characterization

  2021cites this paper
• In-silico modeling of early-stage biofilm formation

  2021cites this paper
• The lytic polysaccharide monooxygenase CbpD promotes Pseudomonas aeruginosa virulence in systemic infection

  2021cites this paper
• Association of an emergency department febrile neutropenia intervention protocol with time to initial antibiotic treatment

  2021cites this paper
• Friends or Foes? Rapid Determination of Dissimilar Colistin and Ciprofloxacin Antagonism of Pseudomonas aeruginosa Phages

  2021cites this paper
• Optimizing Pharmacokinetics-Pharmacodynamics of Antimicrobial Management in Patients with Sepsis: A Review.

  2020cites this paper
• Antimicrobial susceptibility testing: currently used methods and devices and the near future in clinical practice

  2020cites this paper
• Electrochemical Detection of Pyocyanin as a Biomarker for Pseudomonas aeruginosa: A Focused Review

  2020cites this paper
• Bacterial and fungal pathogens isolated from patients with bloodstream infection: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (2012-2017).

  2020cites this paper
• New markers for sepsis caused by Pseudomonas aeruginosa during burn infection

  2020cites this paper
• Applicability of an in-house saponin-based extraction method in Bruker Biotyper matrix-assisted laser desorption/ionization time-of-flight mass spectrometry system for identifying bacterial and fungal species in positively flagged pediatric VersaTREK blood cultures.

  2020cites this paper
• Clinical Significance of Carbapenem-Tolerant Pseudomonas aeruginosa Isolated in the Respiratory Tract

  2020cites this paper
• Time to Appropriate Antibiotic Therapy is an Independent Indicator of Poor Outcome in Children with Nosocomial Klebsiella Pneumoniae Bloodstream Infection

  2020cites this paper
• Pseudomonas aeruginosa bloodstream infections in children: a 9-year retrospective study

  2020cites this paper
• Highlights Regarding The Use Of Metallic Nanoparticles Against Pathogens Considered A Priority By The World Health Organization.

  2020cites this paper
• Predicting Multi-Resistance of Bacteria in an Intensive Care Unit

  2020cites this paper
• Burn- and Trauma-Associated Pulmonary Infection

  2020cites this paper
• Modelling Temporal Relationships in Pseudomonas Aeruginosa Antimicrobial Resistance Prediction in Intensive Care Unit

  2020cites this paper
• Recurrent Pseudomonas aeruginosa Bacteremia

  2020cites this paper
• Characteristics of Pseudomonas Aeruginosa Infection in Pediatric Patients Treated in Sanglah General Hospital Denpasar During Period February 2017 - May 2019

  2020cites this paper
• In vitro analysis of colistin and ciprofloxacin antagonism of Pseudomonas aeruginosa phage PEV2 infection activities

  2020cites this paper
• Vaccines for multidrug resistant Gram negative bacteria: lessons from the past for guiding future success.

  2020cites this paper
• Synergistic effects of zinc oxide nanoparticles and various antibiotics combination against Pseudomonas aeruginosa clinically isolated bacterial strains

  2020cites this paper
• Linking antimicrobial resistance surveillance to antibiotic policy in healthcare settings: the COMBACTE-Magnet EPI-Net COACH project

  2020cites this paper
• Resistance profile of genetically distinct clinical Pseudomonas aeruginosa isolates from public hospitals in central Pakistan.

  2020cites this paper